Several studies have reported diminished expression of TIMP3, a natural inhibitor of ADAM17 activity, contributing to the invasion and migration of tumor cells of various types of epithelial cancers (e.g., thyroid and lung cancers, melanoma, etc.)[37–39]. Here, ADAM17 is linked to melanoma.